Cypress Bioscience (CYPB) volatility Elevated into FDA approval

January 15, 2009 8:44 AM EST Send to a Friend
Cypress Bioscience (Nasdaq: CYPB) : CYPB is recently up $3.38 to $10.59. CYPB's Milnacipran was ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login